MIV Therapeutics Inc. (MIVI) news stock charts
MIV Therapeutics Inc. (MIVI/MIVI.OB) Investment Summary:
MIV Therapeutics, Inc. engages in the research, development, and commercialization of biocompatible coatings for stents, and other medical devices and drug delivery systems. It offers products for providing healing solutions for cardiovascular disease and other medical conditions. The company’s pre-clinical development stage products include bare metal cardiovascular stents and drug-eluting cardiovascular stents. In collaboration with the University of British Columbia, the company developed coating technologies that utilize Hydroxyapatite for application on medical devices and drug delivery systems. The company is based in Vancouver, Canada.www.mivtherapeutics.com
115 Employees
MIV THERAPEUTICS INC (MIVI:Pink OTC Markets Inc)
LAST $0.10 USD
CHANGE TODAY 0.00 0.00%
VOLUME 19.3K
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of MIV THERAPEUTICS INC (MIVI)
|
OPEN
$0.10
|
PREVIOUS CLOSE
$0.10
|
|
|
DAY HIGH
$0.10
|
DAY LOW
$0.10
|
|
|
52 WEEK HIGH
07/23/09 - $0.75
|
52 WEEK LOW
11/3/09 - $0.05
|
|
|
MARKET CAP
1.9M
|
AVERAGE VOLUME 10 D
3.2K
|
|
|
EPS TTM
$-1.15
|
SHARES OUTSTANDING
20.3M
|
|
|
MIVI Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for MIV THERAPEUTICS INC (MIVI)
MIV Therapeutics Inc. Announces Management Changes
12/10/2009
Effective on December 8, 2009, the Board of Directors of MIV Therapeutics Inc. accepted I. Mark Landy's resignation as the company's President and Chief Executive Officer and accepted the consent to act of Patrick A. McGowan on a similar but interim basis in Dr. Landy's stead.
MIV Therapeutics Inc. has Changed its Ticker to MIVI from MIVIE
05/26/2009
Effective May 26, 2009, MIV Therapeutics Inc. changed its OTCPK stock ticker symbol to MIVI from MIVIE.
MIV Therapeutics To Be Deleted From OTCBB
05/22/2009
The common stock of MIV Therapeutics Inc. will be deleted from OTCBB on May 26, 2009 due to failure to comply with NASD 6530. The firm is now added to NBB.
MIV Therapeutics Inc. financial resources
MIVI Competitors
| Company | Last | Change |
| Abbott Laboratories | $53.46 USD | -0.31 |
| Boston Scientific Corp | $7.13 USD | +0.06 |
| Johnson & Johnson | $65.11 USD | +0.05 |
| Medtronic Inc | $44.79 USD | -0.38 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | MIVI | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 1.2x |
|
| Price/Book | 1.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1.7x |
|
|
MIVI |
||
|
MIVI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About MIV Therapeutics Inc.
Would you like to leave a comment about MIV Therapeutics Inc. MIVI/MIVI.OB
Find out what social network information about MIV Therapeutics Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides MIV Therapeutics Inc.'s Stock there is more great penny stock and market information at Realpennies